N-Nitroso-Pramipexole
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Pramipexole is used to treat Parkinson disease. It may be used alone or in combination with other medicines (eg, levodopa). Pramipexole is a dopamine agonist that works on the nervous system to help treat the symptoms of Parkinson disease. Pramipexole is also used to treat Restless Legs Syndrome (RLS). N-Nitroso-Pramipexole is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso-Pramipexole chemically represented as (S)-N-(2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-N-propylnitrous amide .Synchemia is the leading manufacturing and exporter of N-Nitroso-Pramipexole . We supply N-Nitroso-Pramipexole with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143092 |
| CAS No | NA |
| Mol.F. | C16H15ClN4O4S |
| Mol.Wt. | 394.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143093 |
| CAS No | NA |
| Mol.F. | C16H15ClN4O4S |
| Mol.Wt. | 394.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143094 |
| CAS No | NA |
| Mol.F. | C15H13ClN4O4S |
| Mol.Wt. | 380.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143095 |
| CAS No | NA |
| Mol.F. | C14H13ClN4O4S |
| Mol.Wt. | 368.79 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143096 |
| CAS No | NA |
| Mol.F. | C13H17ClN2O6S |
| Mol.Wt. | 364.80 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143097 |
| CAS No | NA |
| Mol.F. | C14H19ClN2O6S |
| Mol.Wt. | 378.82 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143098 |
| CAS No | NA |
| Mol.F. | C15H24N2O4 |
| Mol.Wt. | 296.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143099 |
| CAS No | NA |
| Mol.F. | C18H30N2O6 |
| Mol.Wt. | 370.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143100 |
| CAS No | NA |
| Mol.F. | C12H18N2O3 |
| Mol.Wt. | 238.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143101 |
| CAS No | NA |
| Mol.F. | C14H22N2O4 |
| Mol.Wt. | 282.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143102 |
| CAS No | NA |
| Mol.F. | C15H22N2O5 |
| Mol.Wt. | 310.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143103 |
| CAS No | NA |
| Mol.F. | C9H21N3O2 |
| Mol.Wt. | 203.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143104 |
| CAS No | NA |
| Mol.F. | C6H14N2O3 |
| Mol.Wt. | 162.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143105 |
| CAS No | NA |
| Mol.F. | C16H24N2O5 |
| Mol.Wt. | 324.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143106 |
| CAS No | NA |
| Mol.F. | C15H22N2O5 |
| Mol.Wt. | 310.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143107 |
| CAS No | NA |
| Mol.F. | C14H19N2O5 |
| Mol.Wt. | 295.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |